CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in Auvergne

NCT03378895 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 251

Last updated 2019-01-25

No results posted yet for this study

Summary

The state of health in France appears to be good with regard to major indicators such as life expectancy at birth.

However, France is characterized by a high standardized rate of premature mortality (deaths occurring before the age of 65) in comparison with other European countries, with geographical disparities. Between 2006 and 2010, the standardized rate of premature mortality was higher in Auvergne than the national average.

Chronic diseases such as cardiovascular diseases, cancers and / or metabolic diseases (including diabetes and obesity) are the main causes of these premature deaths. These diseases have several causes: they depend on the genetic heritage, the way of life and the environment. Family history is a known risk factor for these chronic diseases. Eating habits, insufficient physical activity or physical inactivity, excessive drinking and smoking which promote the occurrence of these chronic diseases are the main risk factors that we can modify. Preventive measures are known and are regularly the subject of public health plans and awareness campaigns targeting lifestyles modification of the populations. These prevention campaigns affect entire population, while the risk factors for chronic diseases are different from one to another, this encourages personalization of preventive measures. The CEPPPIA pilot study falls within this framework and aims to evaluate the feasibility of setting up an individualized prevention program on the modification of health behaviors among people aged 35 to 55, who has a moderate risk of developing chronic diseases and residing in Auvergne territory.

Conditions

Interventions

BEHAVIORAL

online questionnaire

Risk assessment identified by online questionnaire

Sponsors & Collaborators

  • European Regional Development Fund

    collaborator OTHER
  • Conseil Régional Auvergne-Rhône-Alpes, Clermont-Ferrand, France.

    collaborator UNKNOWN
  • Agence Régionale de Santé Rhône-Alpes

    collaborator OTHER
  • Ligue Contre le Cancer, Puy de Dôme, Allier et Cantal

    collaborator UNKNOWN
  • GIE Auvergne Thermale

    collaborator OTHER
  • Centre Jean Perrin

    collaborator OTHER
  • UFR Médecine

    collaborator UNKNOWN
  • UFR STAPS

    collaborator UNKNOWN
  • Laboratoire d'Informatique, de Modélisation et d'Optimisation des Systèmes (LIMOS)

    collaborator UNKNOWN
  • Centre de Recherche en Nutrition Humaine d'Auvergne

    collaborator OTHER_GOV
  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Ruddy RICHARD · University Hospital, Clermont-Ferrand

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2018-09-28
Completion
2018-09-28

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03378895 on ClinicalTrials.gov